|
|
|
|
|
DIABETES AND CARBOHYDRATE METABOLISM |
|||
| Chapter Title | Author | ||
| INSULIN AND GLUCAGON PHYSIOLOGY | |||
| Insulin Biosynthesis, Secretion, Structure, And Structure-Activity Relationships | Isaiah Pittman IV, Louis H. Philipson, and Donald F. Steiner 1 | ||
| Glucagon Physiology | Niyaz R. Gosmanov, MD, Adair R Gosmanov, MD, PhD,, and John E. Gerich, MD 2 |
||
| Insulin Signaling and Action: Glucose, Lipids, Protein | Bei Zhzng,PhD, Cal Li, DRPH 3 | ||
| PATHOGENESIS OF DIABETES | |||
| Charles Reasner, MD, Ralph A. DeFronzo, MD and Eugenio Cersosimo MD, PhD 4 | |||
| Pathogenesis Of Type 1A Diabetes | George Eisenbarth, MD 5 | ||
| See also-- Diabetes: Etiology and Pathogenesis | Debra Margulies, MD, Berrin Ergun-Longmire, MD, Svetlana Ten, MD, and Noel Maclaren, M.D. LINK | ||
| Pathogenesis Of Type 2 Diabetes | Eugenio Cersosimo, MD PhD, Ralph A. DeFronzo, M.D., and Lawrence J. Mandarino, Ph.D. 6 | ||
| Non Type 1 - Non Type 2 Diabetes Mellitus | Earle, KE, Rushakoff RJ, and Goldfine ID 7 | ||
| Metabolic Syndrome |
Dara H. Cohen, MD, Derek LeRoith, MD, PHD 8 |
||
| Glucose Toxicity | George Fantus, MD 9 | ||
| Hyperandrogenism, Hirsutism and Polycystic Ovary Syndrome | Richard S Legro, MD link | ||
| Diabetes in the Elderly | Samira Kirmiz, MD and Jane E Weinreb, MD link | ||
| DIABETES TREATMENT- Diagnosis | |||
| Assessing Insulin Sensitivity and Resistance in Humans | Ranganath Munylyappa, MD, Michael Quon, MD 12 | ||
| Pancreatic Islet Func tion Tests | Ruth Weinstock, MD and Streven Zygmont, MD link | ||
| MODALITIES FOR TREATMENT OF DIABETES | |||
| Insulin - Pharmacology, Types of Regimens and Adjustments | Sinan Tanyolac, M.D., Ira D. Goldfine, M.D., Lisa Kroon, PharmD, CDE 14 | ||
| Oral Pharmacological Agents for Type 2 Diabetes: Sulfonylureas, Meglitinides, Metformin, Thiazolidinediones, α-Glucosidase Inhibitors, and Emerging Approaches | Joseph Evans, PhD and Robert Rushakoff, MD 15 | ||
| Dietary, Botanical, and Nutraceutical Treatments for Type 2 Diabetes | Joseph L. Evans, Ph.D. 16 | ||
| DIABETES TREATMENT - STRATEGIES | |||
| The Management of Type 1 Diabetes | Irl B Hirsch, MD and Jay S. Skyler, MD 17 | ||
|
|||
| Medical Nutritional Therapy for the Patient with Diabetes | Anne Shafer,MD, Melissa Weinberg, MD, and Alison Gray, RD 18 | ||
| Management Of Hospitalized Patients | Robert Rushakoff, MD 19 | ||
| Management of Diabetes in Pregnancy | Linda A. Barbour, M.D., M.S.P.H., and Jacob E. Friedman, Ph.D. 20 | ||
| Management of Diabetes in Children (link in) | Berrin Ergun-Longmire, MD, Debra Margulies, MD, Svetlana Ten, MD and Noel Maclaren, MD link | ||
| Monitoring Technologies-Continuous Glucose Monitoring, Biomarkers of Control, Artifical Pancreas | Gloria Yee, RN, CDE, and David Klonoff, MD 22 | ||
| Islet Transplantation | Antonello Pileggi, M.D., Ph.D. 23 | ||
| DIABETIC COMPLICATIONS | |||
| Hyperglycemic Crises: Diabetic Ketoacidosis (DKA), And Hyperglycemic Hyperosmolar State (HHS) | Abbas E Kitabchi, PhD, MD, and Laleh Razavi Nematollahi, MD.24 | ||
| Hypoglycemia During Therapy of Diabetes | Philip Cryer, MD 25 | ||
| Hypertension in Diabetes | Darren M. Allcock, D.O., Stephen A Brietzke, M.D., James R. Sowers, M.D.,26 |
||
| Epidemiology of Cardiovascular Disease in Patients with Diabetes | Ken Feingold, MD 27 | ||
| Management of Dyslipidemia in the Elderly | Dan Streja, MD and Elani Streja, MPH link | ||
| Retinopathy | Jay M. Stewart, MD, Mark Coassin, MD, and Daniel Schwartz, MD 29 | ||
| Diabetic Nephropathy | Allen I. Arieff, M.D., F.A.C.P. 30 | ||
| Diabetic Neuropathies | Aaron Vinik, M.D., Carolina Casellini, M.D. and Marie-Laure Nevoret, M.D. 31 | ||
| Sexual Dysfunction in Diabetes | Tom F. Lue, M.D., William O. Brant, M.D. , Alan Shindel, M.D., and Anthony J Bella, MD, 32 | ||
| TUMOR SYNDROMES | |||
| Insulinoma and Other Hypoglycemias | Alan Siperstein, MD, Orlo H. Clark, MD, and Robert J. Rushakoff,MD 33 | ||
| See also Insulinoma (link in) | EC Filiberti, MD, RR Perry,MD, and Aaron Vinik, MD, PhD | ||
Diabetes Prevention |
|||
| HOME | |||